We spoke to Dr Ramesh Daggubati (New York University Winthrop Hospital, Mineola, NY, USA) about the latest developments in mitral valve technology at C3 2019.
Speaker’s Disclosures: Ramesh Daggubati is a consultant for Abiomed, Meril and Medtronic.
Questions:
1. What is the current status of antiplatelet therapy and dual versus triple antiplatelet therapy? (0:04)
2. Where does the future lie in antiplatelet therapy? (0:49)
3. What are the latest technological developments in mitral valve technology? (1:41)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed in partnership with C3 at the 2019 annual meeting in Orlando, Florida, June 2019.
